Click on the title of each update below to view the full message.
- Government contracting can be daunting; here’s how to get started.
- Tufts University: Pharma spends $4 to $6 billion each year on “procedures that generate extraneous clinical trial data.”
- Every pharmaceutical development program has risks. If realized, major risks can kill your program—life or death, in the business sense.
- Where to find the latest on biodefense and emerging diseases, plus biotech news and events
- September 2012 DynPort newsletter, including an overview of the new consolidated federal procurement system SAM, plus biotech news and events.
- August 2012 DynPort newsletter, including why biodefense is more important than ever, plus science news and events, and summer reading.
- July 2012 DynPort newsletter, featuring a nonclinical toxicology presentation and biotech news and events.
- DynPort's biotech and government contracting newsletter for June 2012 features a clinical quality assurance presentation, plus biotech news, resources and events.
- DynPort's business of biotech video series continues, with EVMS explained, plus biodefense and government contracting news and 25 events.
- We're introducing a video series on educational topics related to biopharmaceutical product development, government contracting and the business of biotech.